Mouse models for
urea cycle disorders have been available for the past 30 y; however, until now, no measurements of
urea production in vivo have been conducted.
Urea entry rate was determined in Otc(spf-ash) and littermate controls employing a primed-continuous infusion of 15N15N
urea. A saline infusion control, a complete mixture of
amino acids (AA), or a
glycine-
alanine (GA) mixture was infused at 86 (AA1 and GA1) and 172 mg N.kg(-1).h(-1) (AA2 and GA2) to impose a defined
nitrogen load on the
urea cycle.
Urea entry rate and plasma
urea concentration increased (P < 0.001) as a consequence of the increase in the infusion rate of the complete mixture of
amino acids, but the 2 genotypes did not differ (P = 0.96 and P = 0.44, respectively). The infusion of the GA mixture, however, decreased (P < 0.001) the plasma
urea concentration and
urea entry rate in Otc(spf-ash) mice compared with controls. At the highest level (GA2),
urea entry rate was further depressed (P < 0.001), Otc(spf-ash) mice became hyperammonemic (1701 +/- 150 micromol/L), and hyperammonemic symptoms were evident. An acute hepatic enlargement (P < 0.001) was also evident in Otc(spf-ash) mice infused with GA2. These results show that despite vestigial OTC activity, Otc(spf-ash) mice were able to maintain ureagenesis at the same rate of control animals when a complete mixture of
amino acids was infused. This implies that Otc(spf-ash) mice are able to dispose of
ammonia, without apparent adverse effects, when a balance mixture of
amino acids is provided, despite reduced
enzyme activity.